[go: up one dir, main page]

AR062142A1 - Composicion farmaceutica que contiene en asociacion saredutant y un inhibidor selectivo de la recaptacion de serotonina o un inhibidor de la recaptacion de serotonina/norepinefrina - Google Patents

Composicion farmaceutica que contiene en asociacion saredutant y un inhibidor selectivo de la recaptacion de serotonina o un inhibidor de la recaptacion de serotonina/norepinefrina

Info

Publication number
AR062142A1
AR062142A1 ARP070103357A ARP070103357A AR062142A1 AR 062142 A1 AR062142 A1 AR 062142A1 AR P070103357 A ARP070103357 A AR P070103357A AR P070103357 A ARP070103357 A AR P070103357A AR 062142 A1 AR062142 A1 AR 062142A1
Authority
AR
Argentina
Prior art keywords
recovery
inhibitor
serotonin
association
norepinefrine
Prior art date
Application number
ARP070103357A
Other languages
English (en)
Inventor
Carolina Louis
Lisa Arvanitis
Guy Griebel
Caroline Cohen
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0607050A external-priority patent/FR2904221B1/fr
Priority claimed from FR0700863A external-priority patent/FR2912057B1/fr
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR062142A1 publication Critical patent/AR062142A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente tiene por objeto composiciones farmacéuticas que contienen en asociacion (S)-(-)-N-[4-(4-acetamido-4-fenilpiperidin-1-il)-2-(3,4-diclorofenil)butil]-N-metilbenzamida o una de sus sales aceptables farmacéuticamente con un inhibidor selectivo de la recaptacion de serotonina o con un inhibidor de la recaptacion de serotonina/norepinefrina.
ARP070103357A 2006-07-31 2007-07-30 Composicion farmaceutica que contiene en asociacion saredutant y un inhibidor selectivo de la recaptacion de serotonina o un inhibidor de la recaptacion de serotonina/norepinefrina AR062142A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0607050A FR2904221B1 (fr) 2006-07-31 2006-07-31 Composition pharmaceutique contenant en association le saredutant et la fluoxetine.
FR0700863A FR2912057B1 (fr) 2007-02-07 2007-02-07 Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine

Publications (1)

Publication Number Publication Date
AR062142A1 true AR062142A1 (es) 2008-10-15

Family

ID=39001699

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103357A AR062142A1 (es) 2006-07-31 2007-07-30 Composicion farmaceutica que contiene en asociacion saredutant y un inhibidor selectivo de la recaptacion de serotonina o un inhibidor de la recaptacion de serotonina/norepinefrina

Country Status (23)

Country Link
US (2) US20080033014A1 (es)
EP (1) EP2049093A2 (es)
JP (1) JP2009545573A (es)
KR (1) KR20090034368A (es)
AR (1) AR062142A1 (es)
AU (1) AU2007283530A1 (es)
BR (1) BRPI0714862A2 (es)
CA (1) CA2658614A1 (es)
CL (1) CL2007002217A1 (es)
CO (1) CO6150152A2 (es)
CR (1) CR10579A (es)
EA (1) EA200970167A1 (es)
EC (1) ECSP099093A (es)
GT (1) GT200900018A (es)
IL (1) IL196570A0 (es)
MA (1) MA30645B1 (es)
MX (1) MX2009001219A (es)
NO (1) NO20090924L (es)
PE (1) PE20080431A1 (es)
TN (1) TN2009000008A1 (es)
TW (1) TW200817003A (es)
UY (1) UY30517A1 (es)
WO (1) WO2008017753A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20140045936A1 (en) * 2011-04-21 2014-02-13 Wake Forest University Health Sciences Cyclopropyl derivatives and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
NL7503310A (nl) * 1975-03-20 1976-09-22 Philips Nv Verbindingen met antidepressieve werking.
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
FR2508035A1 (fr) * 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US4902710A (en) * 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
AU4918796A (en) * 1995-02-10 1996-08-27 Eli Lilly And Company Methods of treating or preventing psychiatric disorders
FR2792835B3 (fr) * 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
WO2007047576A1 (en) * 2005-10-14 2007-04-26 The Board Of Trustees Of The University Of Illinois Pharmacological treatments for sleep disorders
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine

Also Published As

Publication number Publication date
TN2009000008A1 (en) 2010-08-19
CO6150152A2 (es) 2010-04-20
WO2008017753A2 (fr) 2008-02-14
EA200970167A1 (ru) 2009-08-28
TW200817003A (en) 2008-04-16
UY30517A1 (es) 2008-02-29
CA2658614A1 (fr) 2008-02-14
MX2009001219A (es) 2009-02-13
NO20090924L (no) 2009-03-18
WO2008017753A3 (fr) 2009-02-19
MA30645B1 (fr) 2009-08-03
PE20080431A1 (es) 2008-05-26
CR10579A (es) 2009-03-20
US20090227632A1 (en) 2009-09-10
AU2007283530A1 (en) 2008-02-14
EP2049093A2 (fr) 2009-04-22
IL196570A0 (en) 2009-11-18
JP2009545573A (ja) 2009-12-24
ECSP099093A (es) 2009-02-27
BRPI0714862A2 (pt) 2013-07-02
GT200900018A (es) 2010-08-23
KR20090034368A (ko) 2009-04-07
US20080033014A1 (en) 2008-02-07
CL2007002217A1 (es) 2008-03-07

Similar Documents

Publication Publication Date Title
NI200500031A (es) Nuevos procesos para la sintesis de ivabradine y ademas sales que la contienen con un acido aceptable farmaceuticamente.
DE60233608D1 (de) Phenylpiperidinderivate als Serotonin-Wiederaufnahmehemmer
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
EP1930012A4 (en) CELLOOLIGOSACCHARIDE CONTAINING COMPOSITION
EA200500776A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ АГОНИСТ β3-АДРЕНОРЕЦЕПТОРА И ИНГИБИТОР ОБРАТНОГО ЗАХВАТА СЕРОТОНИНА И/ИЛИ НОРЭПИНЕФРИНА, И ЕЕ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ ФУНКЦИИ МОЧЕВОГО ПУЗЫРЯ
EA200500239A1 (ru) Новый способ синтеза (1s)-4-,5-диметокси-1-(метиламинометил)-бензоциклобутана и его солей присоединения и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EP1904069A4 (en) ARYL AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND THEIR USE FOR BLOCKING THE REABSORPTION OF NORADRENALINE, DOPAMINE, AND SEROTONIN
NO20075345L (no) Sublingual belagt tablett
DK1638933T3 (da) N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer
MY163537A (en) 4- [2- (4-methylphenylsulfanyl)phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
MX2009011923A (es) Tetrahidrobenzo-1,4-diazepinas aril- y heteroaril-sustituidas y uso de las mismas para bloquear reabsorcion de norepinefrina, dopamina y serotonina.
EP1827435A4 (en) 4-PHENYL SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF FOR BLOCKING THE RECAPTURE OF NOREPINEPHRINE, DOPAMINE AND SEROTONIN
AR062142A1 (es) Composicion farmaceutica que contiene en asociacion saredutant y un inhibidor selectivo de la recaptacion de serotonina o un inhibidor de la recaptacion de serotonina/norepinefrina
FR2912057B1 (fr) Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
WO2007026219A3 (en) Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
UY29778A1 (es) Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen.
IS8827A (is) 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSR).
NL1026989A1 (nl) Combinatie van serotonineheropnameremmers en norepinefrineheropnameremmers.
NO20071480L (no) Piperidinderivat eller farmasoytisk akseptabelt salt derav
NO20034029L (no) Substituerte dimetyl-[1-(1-fenyl-cykloheksyl)-piperidin-3-yl metyl]-aminerog anvendelse derav som analgetika
HK1105277A (en) 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
CR9768A (es) Asociacion de agonistas de los receptores b3 y de inhibidores de la recaptacion de monoaminas, composicion farmaceutica que la contiene y su utilizacion en terapeutica
ITMI20040153A1 (it) Chiusura con evidenziatore ottico di manomissione per bottiglie di liquori
DK1377550T3 (da) Phenyl-heterocyclyletherderivater som serotonin-re-uptakeinhibitorer
TH43187S1 (th) ตัวล็อคถังบรรจุก๊าซ

Legal Events

Date Code Title Description
FB Suspension of granting procedure